Near Infrared Imaging, Inc.

www.nearinfraredimaging.com

508-384-3800

info@nearinfraredimaging.com

NII is on the cusp of introducing revolutionary products using

photoacoustic imaging technology, vein visualization technology, and

biometrics technology.

The result will be a paradigm shift in the imaging of tissue and

bleeding in the brain, identification of hard-to-locate veins, and

fingerprint identification.

1

NII’s road to causing a paradigm shift in medical imaging begins with the Vein-Eye™

Additional products will be forthcoming in 2015 and 2016.

NII’s mandate is to offer products that are non-contact, non-invasive, photonics based, of the highest quality, affordable and available to the worldwide community.

Using profits from the Vein-Eye, NII will fund:

R&D of the Vein-Eye PLUS,

Completion of a non-contact biometrics data collection device using vein visualization,

Partnering with other strategic companies and the USA military,

R&D of a non-contact and non-invasive detection of bleeding in the brain using our patented Optical Ultrasound Tomography™.

2

3

4

Near Infrared Imaging has been accumulating technologies, developing new

products and funding research since 2009.

NII holds Exclusive Rights to patents developed at Lawrence Livermore National

Laboratory, the City University of New York, and UCLA’s School of Medicine.

NII is owned in part by the Regents of the University of California (UCLA).

NII is owned in part by the City University of New York (CUNY).

NII is owned in part by Lawrence Livermore National Laboratory (LLNL).

Near Infrared Imaging’s first product, the Vein-Eye™, was developed at LLNL.

The Vein-Eye is FDA registered and has passed the stringent and arduous IEC

60601 3rd edition testing at Intertek.

5

There are over 2,700,000 needle sticks every day in the USA.

While vein illumination is important in every needle insertion, it is critically important when the patient is obese, very young, aged and/or has dark skin.

The failure to stick a needle the first time in children causes pain to the child, the child’s family, and the medical practitioner or nurse.

The Vein-Eye solves the most common complaints:

◦ Existing vein illumination devices are too expensive,

◦ Existing vein illumination devices only illuminate veins that can be seen,

◦ Many existing vein illumination devices cannot image both the vein and the needle at the same time, forcing the nurse to stick the vein in the dark.

A recent study done by one of our competitors has shown that patients will travel greater distances to a location with a vein illumination device.

6

The technology is based upon patents assigned to the City University of New York (CUNY) and Lawrence Livermore National Laboratory.

The CUNY technology has been highlighted in over 250 research articles.

On our website is a video of the Vein-Eye AU illuminating veins of S. Forrest, who was born in Jamaica and has a family history of painful and difficult needle sticks.

NII’s technology has the capability to detect small objects, such as tumors, that are near the surface of the skin.

The Vein-Eye was recently highlighted in BioOptics World magazine.

http://www.bioopticsworld.com/articles/2014/06/near-infrared-camera-enables-real-time-accurate-vein-procedures.html

7

The Vein-Eye uses LEDs and the competitors use lasers. Lasers can cause damage to the eyes of the patient or medical practitioner.

The Vein-Eye performed significantly better than the competition when the patient had hair on the hand or arm, dark skin, or collapsed veins.

When most of our competitors introduce a needle into the image of the vein, the needle washes out the images of the vein.

It is also important to determine if a vein is functioning properly and has blood flowing in it, and not just blood standing still.

Below is a video of the Vein-Eye detecting blood actively flowing in the vein.

http://youtu.be/iGH6PNh84IA

The MSRP of the leading selling vein illumination devices range from $5,400 to $25,000. The Vein-Eye has an MSRP in the $1,999 - $2,199 range.

8

Year Unit Sales NII Total Revenue NII’s Profits

2014 1000 $1.2M $500,000

2015 5,000 $5.6M $2.5M

2016 20,000 $20M $8M

2017 60,000 $48M $24M

2018 120,000 $84M $40M

The biggest market will eventually be the patient’s home, as the worldwide trend in medicine is to stay and be treated in the home.

“According to a survey by FIND/SVP Inc’s Advanced Analytics division, the home testing kit market is worth $4.5 billion. For example, even with the high number of blood pressure monitors all ready in the market place, each year over 8 million new blood pressure-monitoring devices are sold.”

These forecasts do not include other products. The revenue projection for all of NII’s existing and planned products in Year 5 exceeds $1B.

9

RETURN ON INVESTMENT

100,000 shares in exchange for $250,000,

200,000 shares in exchange for $500,000,

400,000 shares in exchange for $1,000,000.

Investors are paying between $1 and $2.50 for shares.

There are 1.4M shares Outstanding and 2M Authorized.

NII’s cost of goods per camera: $550 - $750

MSRP: $1,999 - $2,199

Net profit per camera to NII is $400 - $700

EXIT STRATEGY

Every investor has the right to sell their shares. NII’s plan is to return the full

amount of the investment to the inventor by means of dividends.

10

The average cost of a corporate security breach is $7.2M. Retailers lose an average of 7% of annual revenues to theft and fraud by employees. Patient “misidentification” errors cost more than $55B annually in the U.S.A. alone. NII’s technology is multiple modality biometrics and based upon the visualization of subsurface veins and blood vessels - the fastest growing area of biometrics. NII’s multiple modality has an “anti-spoofing” capability to prevent hacking. Near Infrared Imaging (NII) is in search of civilian and military partners to license our biometrics data collection technology to. NII will then work with our partner in order to produce the premier biometric “secure identification and authentication” platform.

.

11

Multi-modal Biometric data collection system

Fingerprint

Finger vein

Palmvein Palmprint

Hand Geometry

Traumatic Brain Injury (TBI) is the leading cause of death for people under the age of 45.

Children are much more vulnerable to TBI as their skulls are thinner.

350,000 sports-related head injuries are treated at U.S. hospital emergency rooms every year.

TBI is a major health issue affecting service members and veterans during times of both peace and war.

Jared

and

Connie

Fox

14

Brain

Breast

Other

LLNL near infrared light patent

Ultrasonic

Ultrasonic/Optical

Conversion Algorithm

2700

Optical Ultrasound Tomography™ is non-

invasive and non-contact

Ultra High Resolution

Optically Converted

Ultrasound Image Pattern

LLNL patent

LLNL patent

LLNL – Lawrence Livermore National Labs